Should I buy or sell Genus stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" GENSF shares. View GENSF analyst ratings or view top-rated stocks .

How have GENSF shares performed in 2023?

Genus' stock was trading at $34.40 on January 1st, 2023. Since then, GENSF shares have decreased by 17.6% and is now trading at $28.3450. View the best growth stocks for 2023 here .

Are investors shorting Genus?

Genus saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 400 shares, an increase of 33.3% from the October 31st total of 300 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is presently 2.0 days. View Genus' Short Interest .

Is Genus a good dividend stock?

Genus (OTCMKTS:GENSF) pays an annual dividend of $0.17 per share and currently has a dividend yield of 1.48%. The dividend payout ratio is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Genus?

Shares of GENSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Genus Stock Price, News & Analysis (OTCMKTS:GENSF)

$28.35

0.00 (0.00%)

(As of 11/30/2023 ET)

Compare

Today's Range: $28.35
▼
$28.35
50-Day Range: $26.79
▼
$28.35
52-Week Range: $26.79
▼
$28.35

Volume: N/A
Average Volume: 650 shs
Market Capitalization: N/A

P/E Ratio: 59.55
Dividend Yield: 0.59%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

About Genus Stock (OTCMKTS:GENSF)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

GENSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GENSF Stock News Headlines

August 4, 2023 | ca.finance.yahoo.com

Genus plc (GENSF)

June 6, 2023 | finance.yahoo.com

With 88% ownership of the shares, Genus plc (LON:GNS) is heavily dominated by institutional owners

December 1, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

May 16, 2023 | marketwatch.com

Genus Expects 2023 Pretax Profit to Fall on Challenges in China's Pig Sector

May 16, 2023 | lse.co.uk

Genus expects China business to swing to loss on weak porcine markets

April 14, 2023 | cbsnews.com

Family members Vern Moore, Velma Genus “You’re my hero in every meaning of the word”

April 4, 2023 | marketwatch.com

Genus Names Jorgen Kokke as Chief Executive Officer Designate

February 23, 2023 | marketwatch.com

Genus Shares Rise After 2023 View Backed, Posted Higher 1H Revenue, Volumes

December 1, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

November 23, 2022 | marketwatch.com

Genus Backs FY 2023 View Following Good Start to Year

October 7, 2022 | benzinga.com

Genus Stock (OTC:GENSF), Analyst Ratings, Price Targets, Predictions

September 16, 2022 | investing.com

Genus Power Infrastructures Ltd (GEOE)

September 8, 2022 | thetimes.co.uk

Genus given lift by China’s pork market

September 8, 2022 | marketwatch.com

Genus FY 2022 Pretax Profit Fell on Lower Performance of a Biological Asset

September 4, 2022 | nz.finance.yahoo.com

Genus (LON:GNS) sheds UK£52m, company earnings and investor returns have been trending downwards for past year

July 21, 2022 | finance.yahoo.com

Form 8.3 - Genus Plc - CORRECTION

June 10, 2022 | uk.finance.yahoo.com

What do city experts think about the outlook for Genus?

May 21, 2022 | uk.finance.yahoo.com

Which way now for the Genus share price?

May 4, 2022 | finance.yahoo.com

Is The Market Rewarding Genus plc (LON:GNS) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

April 2, 2022 | nypost.com

No bulls–t: Genus Plc to breed eco-friendly, low-farting cows

February 14, 2022 | finance.yahoo.com

Genus plc's (LON:GNS) Intrinsic Value Is Potentially 18% Below Its Share Price

February 8, 2022 | nasdaq.com

GENSF After-Hours Quotes

November 24, 2021 | lse.co.uk

Genus shares slump 13% due to Chinese pig market challenges

November 24, 2021 | marketwatch.com

Genus Expects Lower FY 2022 Pretax Profit on China Woes

November 24, 2021 | nasdaq.com

Genus Says Meets Profit Expectations Except In PIC China

November 24, 2021 | thetimes.co.uk

Chinese pig market challenges hit Genus

October 18, 2021 | finance.yahoo.com

Investing in Genus (LON:GNS) five years ago would have delivered you a 189% gain

See More Headlines

Receive GENSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:GENSF
CUSIP: N/A
CIK: N/A
Web: www.genusplc.com
Phone: 441256347100
Fax: N/A
Employees: 3,500
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 59.55
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Jorgen Kokke (Age 55)
Chief Executive Officer & Director
Comp: $731k
Ms. Alison Jane Henriksen ACA (Age 56)
CFO & Executive Director
Comp: $762.3k
Dr. Matt Culbertson
Chief Operating Officer
Dr. Elena Rice
Head of R&D and Chief Scientific Officer
Mr. Daniel William David Hartley
Group General Counsel & Company Secretary
Ms. Angelle R. Rosata
Group Human Resources Director
Mr. Jerry Thompson
Chief Operating Officer of Genus ABS Beef
Dr. Nate Zwald
Chief Operating Officer of Genus ABS Dairy
Andrew Thompson
Head of ABS EMEA
Ms. Janet Duane
Group Financial Controller

Key Competitors

View All Competitors

GENSF Stock Analysis - Frequently Asked Questions

Should I buy or sell Genus stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" GENSF shares.
View GENSF analyst ratings or view top-rated stocks.
How have GENSF shares performed in 2023?: Genus' stock was trading at $34.40 on January 1st, 2023. Since then, GENSF shares have decreased by 17.6% and is now trading at $28.3450.
View the best growth stocks for 2023 here.
Are investors shorting Genus?: Genus saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 400 shares, an increase of 33.3% from the October 31st total of 300 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is presently 2.0 days.
View Genus' Short Interest.

Is Genus a good dividend stock?: Genus (OTCMKTS:GENSF) pays an annual dividend of $0.17 per share and currently has a dividend yield of 1.48%. The dividend payout ratio is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Genus?: Shares of GENSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:GENSF) was last updated on 12/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial